Finance

Senarai
NCYT:LON
Novacyt SA
GBX 39.00
+0.52%
(+0.20) 1H
13 Okt, 4:35:08 PTG GMT+1  ·   GBX
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk NCYT...
Buka
GBX 39.34
Tinggi
GBX 40.40
Rendah
GBX 39.00
Permodalan Pasaran
34.80J
Purata volum
109.27K
Volum
76.22K
tgi 52 mgu
GBX 86.00
rdh 52 mgu
GBX 26.60
Syer tertunggak
37.66J
Bilangan pekerja
228
Buka
GBX 39.34
Tinggi
GBX 40.40
Rendah
GBX 39.00
Permodalan Pasaran
34.80J
Purata volum
109.27K
Volum
76.22K
tgi 52 mgu
GBX 86.00
rdh 52 mgu
GBX 26.60
Syer tertunggak
37.66J
Bilangan pekerja
228
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Perihal Novacyt SA
CEODavid Allmond
Pekerja228
Diasaskan3 Jul 2006
Ibu pejabat-
Sektor-
Laman webnovacyt.com
Laporan sebelumnyaSemua nilai dalam GBP
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam GBP
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
5.12J
5.12J
5.78J
5.78J
Kos barangan yang dijual
2.61J
2.61J
2.56J
2.56J
Kos hasil
2.61J
2.61J
2.56J
2.56J
Perbelanjaan penyelidikan dan pembangunan
1.03J
1.03J
1.06J
1.06J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
4.69J
4.69J
4.65J
4.65J
Belanja kendalian
5.54J
5.54J
5.66J
5.66J
Jumlah belanja kendalian
8.16J
8.16J
8.22J
8.22J
Pendapatan kendalian
-3.04J
-3.04J
-2.44J
-2.44J
Pendapatan bukan kendalian lain
-23.00K
-23.00K
-47.50K
-47.50K
EBT termasuk item luar biasa
-10.16J
-10.16J
-2.91J
-2.91J
EBT tidak termasuk item luar biasa
-2.52J
-2.52J
-2.80J
-2.80J
Belanja cukai pendapatan
-1.81J
-1.81J
-49.50K
-49.50K
Kadar cukai berkesan
17.85%
17.85%
1.70%
1.70%
Belanja kendalian lain
-180.50K
-180.50K
-44.00K
-44.00K
Pendapatan bersih
-8.27J
-8.27J
-2.90J
-2.90J
Margin untung bersih
-161.60%
-161.60%
-50.13%
-50.13%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
149.00K
149.00K
63.00K
63.00K
Belanja faedah
-146.00K
-146.00K
-139.00K
-139.00K
Belanja faedah bersih
3.00K
3.00K
-76.00K
-76.00K
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
3.46J
3.46J
-1.88J
-1.88J
Keuntungan atau kerugian daripada jualan aset
-3.00K
-3.00K
8.00K
8.00K
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google